Blume Capital Management Inc. Sells 2,200 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Blume Capital Management Inc. lessened its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 37.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,600 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the quarter. […]